Cargando…
Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury
Melatonin receptors (MTs) are potential drug targets for stroke therapy. Ramelteon is a selective melatonin receptor agonist used to treat insomnia. In this study we investigated whether ramelteon could attenuate cerebral ischemia in mice. Acute focal cerebral ischemia was induced in mice via middle...
Autores principales: | Wu, Xiao-li, Lu, Shou-sheng, Liu, Meng-ru, Tang, Wei-dong, Chen, Jun-zi, Zheng, Yan-rong, Ahsan, Anil, Cao, Ming, Jiang, Lei, Hu, Wei-wei, Wu, Jia-ying, Chen, Zhong, Zhang, Xiang-nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470806/ https://www.ncbi.nlm.nih.gov/pubmed/32107468 http://dx.doi.org/10.1038/s41401-020-0361-2 |
Ejemplares similares
-
Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010) -
The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
por: Kawabe, Kentaro, et al.
Publicado: (2014) -
Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials
por: Kishi, Taro, et al.
Publicado: (2019) -
The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species
por: Stroethoff, Martin, et al.
Publicado: (2020) -
Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial*
por: Nishikimi, Mitsuaki, et al.
Publicado: (2018)